Grading of mucositis in patients receiving high-dose therapy with autologous or allogeneic stem cell support.

被引：0
|
作者：
Borén, S
Berndtson, M
Gustavsson, C
Juliusson, G
机构：
[1] Linkoping Univ Hosp, Dept Hematol, S-58185 Linkoping, Sweden
[2] Linkoping Univ Hosp, Hosp Dent, S-58185 Linkoping, Sweden
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
N925
引用
收藏
页码：S247 / S247
页数：1
相关论文
共 50 条
  • [41] PRESENT INDICATIONS FOR THE TREATMENT OF HEMATOLOGIC MALIGNANCIES WITH HIGH-DOSE RADIOCHEMOTHERAPY AND ALLOGENEIC OR AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT
    BEELEN, DW
    SCHAEFER, UW
    TUMORDIAGNOSTIK & THERAPIE, 1994, 15 (06) : 207 - 228
  • [42] New approaches for reduction of oral mucositis in patients undergoing high-dose chemotherapy with haematopoietic stem cell support
    Collova', E
    Castagna, L
    Nozza, A
    Perfetti, V
    Patrone, F
    Danova, M
    Santoro, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S323 - S324
  • [43] High-dose therapy and autologous stem cell transplantation in multiple sclerosis patients: The Russian experience
    Shevchenko, Yu. L.
    Novik, A. A.
    Kuznetzov, A. N.
    Afanasyev, B. V.
    Lisukov, I. A.
    Malysheva, A. N.
    Kulagin, A. D.
    Melnichenko, V. J.
    Ionova, T. I.
    Bisaga, G. N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 261 - 261
  • [44] Palifermin use appears to reduce the severity of oral mucositis in patients receiving high-dose chemotherapy and stem cell transplantation
    Reactions Weekly, 2006, 1114 (1) : 4 - 4
  • [45] Storage of autologous peripheral blood pheresis product in modified fluid gelatin decreases time to engraftment for patients with metastatic breast cancer receiving high-dose chemotherapy (HDC) with stem cell support.
    Myhand, R
    Babior, B
    Fields, V
    Reeb, B
    Alexander, B
    Smith, D
    BLOOD, 1997, 90 (10) : 4244 - 4244
  • [46] Risk factors for oral mucositis (OM) in multiple myeloma (MM) patients receiving high-dose melphalan (Mel) prior to autologous stem cell transplantation (SCT).
    Bhatnagar, Bhavana
    Goloubeva, Olga G.
    Gilmore, Steven
    Hoffman, Arnold
    Ruehle, Kathleen
    Akpek, Gorgun
    Rapoport, Aaron
    Yanovich, Saul
    Badros, Ashraf Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] Bone mineral density of the left femoral neck in lymphoma survivors treated with high dose therapy with autologous stem cell support.
    Seland, Mette
    Smeland, Knut Halvor B.
    Holte, Harald
    Bjoero, Trine
    Godang, Kristin
    Bollerslev, Jens
    Fossa, Sophie D.
    Kiserud, Cecilie E.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [48] Role of high-dose melphalan with autologous stem cell transplantation in multiple myeloma patients receiving botezomib-containing induction therapy
    Bo-Hee Lee
    Seung Hwan Shin
    Chang-Ki Min
    Ho-Young Yhim
    Jae-Yong Kwak
    Jeong-A Kim
    International Journal of Hematology, 2013, 97 : 634 - 639
  • [49] Role of high-dose melphalan with autologous stem cell transplantation in multiple myeloma patients receiving botezomib-containing induction therapy
    Lee, Bo-Hee
    Shin, Seung Hwan
    Min, Chang-Ki
    Yhim, Ho-Young
    Kwak, Jae-Yong
    Kim, Jeong-A
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (05) : 634 - 639
  • [50] Nonmyeloablative conditioning and allogeneic stem cell transplantation as consolidation therapy after high-dose melphalan and autologous stem cell transplantation for multiple myeloma
    Schneider, P
    Fenk, R
    Bernhard, A
    Huenerlituerkoglu, AN
    Aivado, M
    Wehmeier, A
    Pape, H
    Haas, R
    Kobbe, G
    BONE MARROW TRANSPLANTATION, 2002, 29 : S101 - S101
12345